Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
Immunocore (Nasdaq: IMCR) will present at the 25th Annual Needham Virtual Healthcare Conference with a fireside chat on April 13, 2026 at 3:00 p.m. EDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Immunocore (Nasdaq: IMCR) will present at the 25th Annual Needham Virtual Healthcare Conference with a fireside chat on April 13, 2026 at 3:00 p.m. EDT. The presentation will be webcast live and a replay will be available for a limited time via the company website.
Details
News Market Reaction – IMCR
On Apr 6, the day this news came out, IMCR closed 3.60% above the previous close.
Data tracked by StockTitan Argus for the Apr 6 session.
Key Figures
- Conference edition
- 25th Annual
- Needham Virtual Healthcare Conference
- Conference date
- April 13, 2026
- Fireside chat schedule
- Presentation time
- 3:00 p.m. EDT
- Needham fireside chat
Historical Context
-
Planned five-year overall survival data presentation for KIMMTRAK at AACR 2026.
-
Management participation in multiple March 2026 investor conferences with webcasts.
-
Reported FY2025 KIMMTRAK sales, narrowed net loss, and key 2026 data timelines.
-
Announcement of Q4 and FY2025 results date and related investor call details.
-
R&D leadership transition with internal promotions and emphasis on Phase 3 trials.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
(OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 06 April 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate in the 25th Annual Needham Virtual Healthcare Conference.
25th Annual Needham Virtual Healthcare Conference
Fireside Chat: Monday, April 13, 2026, at 3:00 p.m. EDT
The presentation will be webcast live and can be accessed by visiting ‘Events & Presentations’, under ‘Events’, via the ‘Investors’ section of Immunocore’s website at www.immunocore.com. Following the event, a replay of the presentation will be made available for a limited time.
About Immunocore
Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, autoimmune diseases and infectious diseases. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including clinical and pre-clinical programs in oncology, infectious diseases, and autoimmune diseases. The Company’s most advanced oncology TCR therapeutic, KIMMTRAK, has been approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.
Contact Information
Immunocore
Sébastien Desprez, Head of Communications
T: +44 (0) 7458030732
E: sebastien.desprez@immunocore.com
Follow on LinkedIn: @Immunocore
Investor Relations
Morgan Morse
T: +1 (215) 384-4781
E: ir@immunocore.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.